Report #2891263

Overview

Sex

Male

Age

Age unknown

State

—

Recovered

Not recovered

Vaccinated

—

Onset

—

Days to onset

—

Hospital days

—

Symptoms (1)

Symptom narrative

muscle weakness in the lower extremities; This spontaneous case was reported by a consumer and describes the occurrence of MUSCULAR WEAKNESS (muscle weakness in the lower extremities) in a male patient of an unknown age who received mRNA-1283 (MNEXSPIKE PFS) for COVID-19 prophylaxis. The suspect product included Pre-filled Syringe injection for COVID-19 prophylaxis. Previously administered products included for Product used for unknown indication: Covid-19 vaccine (Patient received a COVID-19 vaccine 3 years ago) in 2023. Past adverse reactions to the above products included No adverse effect with Covid-19 vaccine. On an unknown date, the patient received dose of mRNA-1283 (MNEXSPIKE PFS) (Intramuscular use) 1 dosage form and Pre-filled Syringe (unknown route) at an unspecified dose. On an unknown date, the patient experienced MUSCULAR WEAKNESS (muscle weakness in the lower extremities). At the time of the report, MUSCULAR WEAKNESS (muscle weakness in the lower extremities) had not resolved. Concomitant medication was not provided. The patient developed the adverse reaction for a while. The reporter did not provide any information despite asking for the details of the event and the call ended abruptly after providing this information. It was unknown if the patient experienced any additional symptoms or events. Treatment medication was not reported.